sodium chloride

Generic: sodium chloride

Labeler: fresenius kabi usa, llc
NDC Directory HUMAN PRESCRIPTION DRUG UNAPPROVED DRUG OTHER Inactive Finished

Drug Facts

Product Profile

Brand Name sodium chloride
Generic Name sodium chloride
Labeler fresenius kabi usa, llc
Dosage Form INJECTION
Routes
INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Active Ingredients

sodium chloride 234 mg/mL

Manufacturer
Fresenius Kabi USA, LLC

Identifiers & Regulatory

Product NDC 63323-187
Product ID 63323-187_177b998e-8236-4200-9434-9072a2b5d444
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category UNAPPROVED DRUG OTHER
Listing Expiration 2026-12-31
Marketing Start 2000-09-05

Pharmacologic Class

Classes
increased large intestinal motility [pe] inhibition large intestine fluid/electrolyte absorption [pe] osmotic activity [moa] osmotic laxative [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 63323187
Hyphenated Format 63323-187

Supplemental Identifiers

RxCUI
1807571
UPC
0363323187309
UNII
451W47IQ8X

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name sodium chloride (source: ndc)
Generic Name sodium chloride (source: ndc)
Routes
INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 234 mg/mL
source: ndc
Packaging
  • HOW SUPPLIED Sodium Chloride Injection, USP (4 mEq/mL) is supplied as follows: Product No NDC No Volume 18730 63323-187-30 30 mL in a 30 mL vial These vials are Single Dose Vials; packaged 25 vials per tray. Preservative Free. Discard unused portion. Use only if solution is clear and seal intact. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].
  • PACKAGE LABEL - PRINCIPAL DISPLAY - Sodium Chloride 30 mL Single Dose Vial NDC 63323-187-30 18730 Sodium Chloride Injection, USP Concentrated 23.4% 4 mEq/mL Must be Diluted Prior to IV Administration Rx only 30 mL Single Dose Vial 18730-vial
source: label

Packages (0)

No package records.

Ingredients (1)

sodium chloride (234 mg/mL)

Linked Drug Pages (1)

Sodium Chloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "177b998e-8236-4200-9434-9072a2b5d444", "openfda": {"upc": ["0363323187309"], "unii": ["451W47IQ8X"], "rxcui": ["1807571"], "spl_set_id": ["ea5d8afd-c986-4290-857f-15d86713f71e"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [], "brand_name": "Sodium Chloride", "product_id": "63323-187_177b998e-8236-4200-9434-9072a2b5d444", "dosage_form": "INJECTION", "pharm_class": ["Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]"], "product_ndc": "63323-187", "generic_name": "SODIUM CHLORIDE", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Sodium Chloride", "active_ingredients": [{"name": "SODIUM CHLORIDE", "strength": "234 mg/mL"}], "marketing_category": "UNAPPROVED DRUG OTHER", "marketing_start_date": "20000905", "listing_expiration_date": "20261231"}